[DOC] Nebulised Pentamidine - Administration - Health (act.gov.au),http://www.health.act.gov.au/sites/default/files/2019-02/Nebulised%2520Pentamidine%2520-%2520Administration.docx
[DOC] https://journals.plos.org/plosntds/article/file?ty...,https://journals.plos.org/plosntds/article/file%3Ftype%3Dsupplementary%26id%3Dinfo:doi/10.1371/journal.pntd.0009276.s001
[DOC] journals.plos.org/plosntds/article/asset?unique&id...,http://journals.plos.org/plosntds/article/asset%3Funique%26id%3Dinfo:doi/10.1371/journal.pntd.0008380.s003
[DOC] https://stacks.cdc.gov/view/cdc/34523/cdc_34523_DS...,https://stacks.cdc.gov/view/cdc/34523/cdc_34523_DS3.docx
[DOC] https://www.biorxiv.org/content/biorxiv/early/2019...,https://www.biorxiv.org/content/biorxiv/early/2019/03/11/573329/DC1/embed/media-1.docx%3Fdownload%3Dtrue
[DOC] AusPAR Attachment 1 - Therapeutic Goods Administration (TGA),https://www.tga.gov.au/sites/default/files/auspar-insulin-glargine-150828-pi.docx
[DOC] Supplementary Figure S01 - Dove Medical Press,https://www.dovepress.com/get_supplementary_file.php%3Ff%3D244903.docx
[DOC] Molecular insight into drugs binding to ctDNA: the ... - IRIS Uni Torino,https://iris.unito.it/retrieve/handle/2318/1851575/969279/MCCM.docx
[DOC] https://doi.org/10.1371/journal.pntd.0009734.s007,https://doi.org/10.1371/journal.pntd.0009734.s007
[DOC] Guideline Development Group (GDG) Members,http://links.lww.com/JPHO/A177
